scispace - formally typeset
Open AccessJournal ArticleDOI

The inflammatory response in sepsis.

Markus Bosmann, +1 more
- 01 Mar 2013 - 
- Vol. 34, Iss: 3, pp 129-136
Reads0
Chats0
TLDR
Recent insights into the signaling pathways in immune and phagocytic cells that underlie sepsis and SIRS are discussed and how these might be targeted for therapeutic interventions to reverse or attenuate pathways that lead to lethality during sepsi are considered.
About
This article is published in Trends in Immunology.The article was published on 2013-03-01 and is currently open access. It has received 382 citations till now. The article focuses on the topics: Systemic inflammatory response syndrome & Septic shock.

read more

Citations
More filters
Journal ArticleDOI

System-wide molecular dynamics of endothelial dysfunction in Gram-negative sepsis

TL;DR: The novel findings reported here provide a broader picture of the molecular dynamics that take place in whole organism vascular beds in Gram-negative sepsis inflammation, and can pave the way for future therapeutic strategies aimed at intervening in specific protein synthesis mechanisms of the vascular unit during acute inflammatory processes.
Journal ArticleDOI

Actualización en sepsis y choque séptico: nuevas definiciones y evaluación clínica

TL;DR: Este articulo proporciona una revision completa of the sepsis, abarcando las nuevas definiciones, fisiopatologia and recomendaciones sobre el diagnostico y tratamiento.
Journal ArticleDOI

Selective inhibition of interleukin-1 receptor-associated kinase 1 ameliorates lipopolysaccharide-induced sepsis in mice

TL;DR: Jh-X-119-01 selectively inhibited activation of IRAK1 and protected mice from LPS-induced sepsis and showed less toxicity on macrophages comparing with a non-selective IRAK 1/4 inhibitor.
Journal ArticleDOI

SMARCB1 Promotes Ubiquitination and Degradation of NR4A3 via Direct Interaction Driven by ROS in Vascular Endothelial Cell Injury.

TL;DR: It is reported that NR4A3 protein abundance is decreased immensely in VEC injury induced by reoxygenation after oxygen-glucose deprivation (OGD-R), which is significantly blocked by the administration of the antioxidative steroid TRIOL.
Journal ArticleDOI

Is Regular Probiotic Practice Safe for Management of Sepsis

TL;DR: In this article, the beneficial or harmful effects associated with probiotic therapy in sepsis were discussed. But, probiotic use in neonatal and athymic adult mice fail to provide any beneficial effects on mortality and sepssis-induced inflammation.
References
More filters
Journal ArticleDOI

Free radicals and antioxidants in normal physiological functions and human disease

TL;DR: Attention is focussed on the ROS/RNS-linked pathogenesis of cancer, cardiovascular disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes mellitus, neurodegenerative diseases, rheumatoid arthritis, and ageing.
Journal ArticleDOI

The Epidemiology of Sepsis in the United States from 1979 through 2000

TL;DR: The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987, and the total in-hospital mortality rate fell, yet the total number of deaths continued to increase.
Journal ArticleDOI

The acute respiratory distress syndrome.

TL;DR: Progress has been made in understanding the mechanisms responsible for the pathogenesis and the resolution of lung injury, including the contribution of environmental and genetic factors, and on developing novel therapeutics that can facilitate and enhance lung repair.
Journal ArticleDOI

Immunodesign of experimental sepsis by cecal ligation and puncture.

TL;DR: Standardized procedures for inducing sepsis in mice and rats are defined by applying defined severity grades of sepsi through modulation of the position of cecal ligation.
Journal ArticleDOI

Immunosuppression in patients who die of sepsis and multiple organ failure.

TL;DR: Patients who die in the ICU following sepsis compared with patients who die of nonsepsis etiologies have biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression, and targeted immune-enhancing therapy may be a valid approach in selected patients with sepsi.
Related Papers (5)